These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36823555)

  • 1. ITDetect: a method to detect internal tandem duplication of FMS-like tyrosine kinase (FLT3) from next-generation sequencing data with high sensitivity and clinical application.
    Lee S; Sun CH; Jang H; Kim D; Yoon SS; Koh Y; Na SC; Cho SI; Kim MJ; Seong MW; Byun JM; Yun H
    BMC Bioinformatics; 2023 Feb; 24(1):62. PubMed ID: 36823555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate Detection and Quantification of FLT3 Internal Tandem Duplications in Clinical Hybrid Capture Next-Generation Sequencing Data.
    Tung JK; Suarez CJ; Chiang T; Zehnder JL; Stehr H
    J Mol Diagn; 2021 Oct; 23(10):1404-1413. PubMed ID: 34363960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.
    He R; Devine DJ; Tu ZJ; Mai M; Chen D; Nguyen PL; Oliveira JL; Hoyer JD; Reichard KK; Ollila PL; Al-Kali A; Tefferi A; Begna KH; Patnaik MM; Alkhateeb H; Viswanatha DS
    Mod Pathol; 2020 Mar; 33(3):334-343. PubMed ID: 31471587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive review and evaluation of computational methods for identifying FLT3-internal tandem duplication in acute myeloid leukaemia.
    Yuan D; He X; Han X; Yang C; Liu F; Zhang S; Luan H; Li R; He J; Duan X; Wang D; Zhou Q; Gao S; Niu B
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33851200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
    Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
    J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously.
    Mezei ZA; Tornai D; Földesi R; Madar L; Sümegi A; Papp M; Antal-Szalmás P
    J Biotechnol; 2019 Sep; 303():25-29. PubMed ID: 31302157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of next-generation sequencing and fragment analysis for the detection and allelic ratio determination of FLT3 internal tandem duplication.
    Kim JJ; Lee KS; Lee TG; Lee S; Shin S; Lee ST
    Diagn Pathol; 2022 Jan; 17(1):14. PubMed ID: 35081962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid Leukemia.
    Oduro KA; Spivey T; Moore EM; Meyerson H; Yoest J; Tomlinson B; Beck R; Alouani D; Sadri N
    Mod Pathol; 2024 Sep; 37(9):100534. PubMed ID: 38852814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection the Frequency and Characteristics of FLT3 Internal Tandem Duplication Mutations by Capillary Electrophoresis Assay and Next-Generation Sequencing in.
    Ma L; Cao Y; Jiang Y; Cong X; Lu S; Shen J; Liu Q; Han C; Zhan Y; Cao Y
    Clin Lab; 2016 Oct; 62(10):2065-2072. PubMed ID: 28164543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
    Marhäll A; Heidel F; Fischer T; Rönnstrand L
    Ann Hematol; 2018 May; 97(5):773-780. PubMed ID: 29372308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing molecular architecture of FLT3 internal tandem duplication: Development and clinical validation of a web-based application to generate accurate nomenclature.
    Ding Y; Smith GH; Deeb K; Schneider T; Campbell A; Zhang L
    Int J Lab Hematol; 2022 Oct; 44(5):918-927. PubMed ID: 35795913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological Advances:
    Akabari R; Qin D; Hussaini M
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms.
    Tsai HK; Brackett DG; Szeto D; Frazier R; MacLeay A; Davineni P; Manning DK; Garcia E; Lindeman NI; Le LP; Lennerz JK; Gibson CJ; Lindsley RC; Kim AS; Nardi V
    J Mol Diagn; 2020 Sep; 22(9):1162-1178. PubMed ID: 32603763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations.
    Shoukier M; Kadia T; Konopleva M; Alotaibi AS; Alfayez M; Loghavi S; Patel KP; Kanagal-Shamanna R; Cortes J; Samra B; Jabbour E; Garcia-Manero G; Takahashi K; Pierce S; Short NJ; Yilmaz M; Sasaki K; Masarova L; Pemmaraju N; Borthakur G; Kantarjian HM; Ravandi F; DiNardo CD; Daver N
    Cancer; 2021 Feb; 127(3):381-390. PubMed ID: 33119202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in
    Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S
    Indian J Med Res; 2016 May; 143(Supplement):S11-S16. PubMed ID: 27748272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with
    Levis MJ; Perl AE; Altman JK; Gocke CD; Bahceci E; Hill J; Liu C; Xie Z; Carson AR; McClain V; Stenzel TT; Miller JE
    Blood Adv; 2018 Apr; 2(8):825-831. PubMed ID: 29643105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.
    Zhong L; Jia YQ; Meng WT; Ni X
    Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.
    Kayser S; Schlenk RF; Londono MC; Breitenbuecher F; Wittke K; Du J; Groner S; Späth D; Krauter J; Ganser A; Döhner H; Fischer T; Döhner K;
    Blood; 2009 Sep; 114(12):2386-92. PubMed ID: 19602710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of High-throughput Sequencing in Acute Myeloid Leukemia Patients with Positive FLT3-ITD].
    Ma L; Jiang YW; Wang ST; Liu Q; Cong X; Shen J; Cao YY; Cao YT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):381-7. PubMed ID: 27150996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.